PubMed Health⌕ Search

Biomedical subjects

W Rapp

Publications and source records attributed to W Rapp.

At least 55 records · Page 3Linked to original sources

Purification of human gastric proteases by immunoadsorbents: pepsinogen II-group.

The pepsinogen II group was prepared from gastric mucosal extract by a two-step procedure consisting of immunoadsorption to an anti-pepsinogen II column, followed by ion exchange chromatography on DEAE-Sephadex A-50. The final product was pure according to biochemical and immunochemical criteria. As determined by quantitative immunodiffusion, the enrichment factor of pepsinogen II was 34. A recovery of 55% was calculated. The effectiveness of this procedure was due to the use of purified anti-pepsinogen II antibodies for immunoadsorption. This was achieved by immunoadsorption to Sepharose bound crude pepsinogen and a further passage over an unrelated immunoadsorbent (human serum coupled to Sepharose). The immunoadsorbent prepared using purified anti-pepsinogen antibodies showed low non-biospecific binding of gastric extract proteins. Complete separation of pepsinogen II from pepsinogen I was observed in one single passage. Purified pepsinogen II showed two protein bands in polyacrylamide gel electrophoresis and four bands of proteolytic activity in agarose enzyme electrophoresis. In both methods, as well as in two-dimensional immunoelectrophoresis, components with the same electrophoretic mobility were detected in pure preparations of group and II pepsinogens. Consequently, only in pure preparations was it possible to define the exact number of bands belonging to each of the two groups and to assess the immunological specificity of every band. Upon hydroxyapatite chromatography purified pepsinogen II was further resolved into two fractions.

Blood Proteins↗

Purification of human gastric proteases by immunoadsorbents. Pepsinogen I group.

Human pepsinogen I group was purified by immunoadsorption techniques. Gastric mucosal extracts containing the pepsinogen I group and the pepsinogen II group and concentrated urine containing only pepsinogen I group were separated by DEAE-ion-exchange chromatography to remove the bulk of human serum protein. Fractions displaying proteolytic activity were further purified by adsorption on an anti-pepsinogen I group Sepharose immunoadsorbent column. After desorption, gastric pepsinogen I group was separated from pepsinogen II group. Trace amounts of contaminating protein were removed from preparations from gastric mucosal extracts and urine by passage over an anti-human serum immunoadsorbent column. The purity of pepsinogen I group from both sources was assessed by electrophoretic and immunological criteria. The isolated pepsinogen I group from gastric mucosal extracts and urine were by biochemical and immunochemical criteria identical with each other and with the pepsinogen I group in the unfractionated starting materials. By agarose enzyme electrophoresis four bands were detected and it was determined that the proteases of the pepsinogen I group express the same individual antigenic determinant.

Adult↗

Controlled trial of penfluridol and thiothixene in the maintenance treatment of chronic schizophrenic syndromes.

In a controlled trial of penfluridol and thiothixene as maintenance drugs in patients with chronic schizophrenic syndromes, some improvement over previous neuroleptics was seen with both drugs. This improvement was mainly evident in variables concerned with participation in social activities as assessed with the S-scale and by ward behaviour. The drug dosages necessary were very low and gave few and easily manageable side-effects. There was no significant difference between penfluridol and thiothixene. Penfluridol has the clear practical advantage of being the only long-acting drug for oral administration so far available.

Adolescent↗

Penfluridol and thiothixene. Dosage, plasma levels and changes in psychopathology.

Plasma levels of penfluridol and thiothixene were studied after 4 weeks treatment in a double-blind controlled trial of 47 patients suffering from chronic schizophrenic syndromes. There was found a tenfold variation in plasma levels for penfluridol, and about a twentyfold variation for thiothixene. For penfluridol, a significant correlation between dosage and plasma level and also between dosage and changes in psychopathology as regards factor 5 in the Märtens & Jonsson S scale which comprises the items most characteristic of a schizophrenic syndrome, was found. For thiothixene, a significant correlation between plasma levels and changes in factor 5 was found. A gas-chromatographic method for penfluridol is also described.

Adult↗

Quantitation of alpha1-acid glycoprotein in neutralized gastric juice by electroradioimmunoassay (ERIA).

Alpha1-Acid glycoprotein (AGP) was quantitated by an electroradioimmunoassay (ERIA) in in vivo neutralized gastric juice (nGJ) of 226 patients, including normals and patients with various gastic diseases. The accuracy of ERIA was tested by extraction and recovery experiments. A possible interference of nGJ constituents with the quantitation procedure was excluded. The mean AGP concentration in gastric juice of normals was 1.04 mu/ml (range 0.04-4.1 mu/ml). The concentration was significantly higher in the gastric cancer group (mean 31.6 mu/ml, p less than 0.01), in the group of chronic metaplastic gastritis (mean 5.7 mu/ml, p less than 0.01) and in the group of BII resections (mean 8.8 mu/ml, p less than 0.05). In 6 out of 12 nGJ samples with high AGP concentrations, a spur formation (Ouchterlony type III) was observed in double gel diffusion when compared to serum AGP. In 3 out of these 12 samples, the dilution curve in ERIA differed from the serum AGP dilution curve. These results indicate a difference in the antigenic properties of AGP in nGJ.

Adolescent↗

Alpha 1-acid glycoprotein in gastric cancer juice.

Gastric juice was neutralized (nGJ) in vivo by 80 ml of a phosphate buffer containing radiolabelled vitamin B12 as dilution indicator. Unprocessed nGJ was analyzed in the double gel diffusion technique for the presence of serum proteins using monospecific antisera. Alpha1-Acid glycoprotein (AGP) was found in a high incidence (36 out of 38 subjects) in nGJ of gastric cancer patients. AGP was also observed less frequently in nGJ of patients with Billroth II resections (6/15), metaplasia (11/52), gastric ulcer (3/24), chronic atrophic gastritis (2/26) and chronic gastritis (3/63). AGP was absent in the control group (0/21), in patients with surface gastritis (0/38) and in subjects with normal acid secretion (0/45). Immunochemical studies demonstrated no identity of AGP with human "gastrointestinal tumor associated antigens." In 7 out of 17 AGP positive samples immunochemical differences between gastric and serum AGP were observed.

Adolescent↗